Composition, form of production and packaging
Capsules of blue color, soft, oblong, shiny, with a capacity from 0.27 ml to 0.333 ml; the contents of the capsules are a viscous solution of blue color.
dimethicone 300 mg
guayazulene 4 mg
Excipients: gelatin - 131.5 mg, glycerol - 31.2 mg, sorbitol 70% non-crystallizable - 21 mg, proprietary blue V - 0.2 mg, titanium dioxide - 1.1 mg, purified water - sufficient amount.
10 pieces. - blisters (3) - packs of cardboard.
Gel for ingestion of blue color, with a mint smell.
dimethicone 3 g
guayazulene 4 mg
Auxiliary substances: sorbitol 70% crystallizable - 1.429 g (corresponding amount of sorbitol - 1 mg), carrageenates - 0.13 g, sodium cyclamate - 0.012 g, methyl parahydroxybenzoate - 0.015 g, peppermint oil - 0.003 g, purified water - 5.407 g.
10 g - sachets (12) - packs of cardboard.
10 g - sachets (14) - packs of cardboard.
10 g - sachets (30) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2016.
Combined drug. Has anti-inflammatory effect, reduces the secretion of hydrochloric acid in the stomach, reduces gas formation in the intestine.
Gvayazulen has a pronounced anti-inflammatory effect, weakens allergic reactions, enhances regenerative processes, has an antioxidant effect. Due to the inhibitory effect on the release of histamine from mast cells, gastric mucosa cells, inhibits acid secretion.
Dimethicone is a hydrophobic polymeric substance with a low surface tension, which reduces gassing in the intestine and covers the protective film of the wall of the digestive canal.
Data on the pharmacokinetics of Pepsan-R is not available.
- Gastroesophageal reflux disease of 0-I degree;
- increased acidity of gastric juice;
- Functional disorders of the digestive tract, manifested by heartburn, eructation, increased gas production, nausea, constipation and / or diarrhea, or alternation;
- Preparation for X-ray, ultrasound or instrumental examination of abdominal organs.
The drug is taken orally.
Assign 1 capsule or sachet 2-3 times / day before eating or when there is pain. The course of treatment is determined individually.
When preparing for studies of the abdominal cavity organs , 1 capsule or sachet is prescribed 2-3 times a day before the test and 1 capsule or sachet on the morning of the study day.
Rarely: allergic reactions, pain, bloating.
- Children under the age of 14 years (capsules);
- Children and adolescence up to 18 years (gel for oral administration);
- rare hereditary diseases, such as intolerance to fructose, glucose-galactose malabsorption, insufficiency of sucrose-isomaltase (because the drug contains sorbitol);
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
Possible use of the drug during pregnancy and during breastfeeding.
APPLICATION FOR CHILDREN
Contraindicated in children under 14 years (capsules), in children and adolescents under 18 years (gel for oral administration).
Pepsan-P does not contain sugar, so it is not contraindicated in patients with diabetes mellitus.
Impact on the ability to drive vehicles and manage mechanisms
The drug does not affect the ability to perform potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions (including vehicle management, work with moving mechanisms).
There may be an increase in side effects.
Treatment: symptomatic therapy.
Drug interaction is not established.
TERMS OF RELEASE FROM PHARMACY
The drug is released by prescription.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of reach of children at a temperature of no higher than 25 В° C. The shelf life of the capsules is 4 years, the gel for oral administration is 2 years.